NorthWest Biotherapeutics Inc (NWBO)

[H2R]

"Keep Calm" like they say in the U.K.

We are experiencing short term volatility. To put a bit of perspective, the stock has been on a long term uptrend thanks to Woody. And within the next few months to a year, a number of catalysts will happen, even if it feels it's never fast enough. Among those catalysts:

- Completion of enrollment for DCVax-L/GBM (Glioblastoma) Phase III trial (Yes, it will be slower than we Longs want)
- First Interim Analysis and Recommendation (could be good news too:)
- DCVax-DIRECT Phase II Trial Announcement(scientific opinion)
- PIM/EAMS - Act 2 :)
- Germany HE (Health Exemption) negotiations with Health Funds on reimbursement finalization

- Possible Announcement of CI (Checkpoint Inhibitor) combination trial

The story has not changed. It takes a while, that's the name of the game. If you 'believe' the story, the potential benefits for patients, the seriousness of the company, their manufacturing preparation, then the short term volatility is just a bump in the road. Nothing fun, for sure, but in a year, two years, that bump will look pretty darn small. Whichever way we end up.

Good Luck to Longs and Cancer Patients!